Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 09:30 am Purchase | 2024-12-31 | 13G | PROTARA THERAPEUTICS INC TARA | Adage Capital Management, L.P. | 2,250,000 6.560% | 2,250,000 (New Position) | Filing History |
| 2024-12-17 4:02 pm Purchase | 2024-12-10 | 13G | PROTARA THERAPEUTICS INC TARA | Velan Capital Investment Management LP | 2,059,000 5.900% | 2,059,000 (New Position) | Filing History |
| 2024-11-18 06:01 am Sale | 2024-09-30 | 13G | PROTARA THERAPEUTICS INC TARA | Opaleye Management Inc. | 1,681,154 8.150% | -827,318 (-32.98%) | Filing History |
| 2024-11-14 1:00 pm Purchase | 2024-09-30 | 13G | PROTARA THERAPEUTICS INC TARA | Woodline Partners LP | 1,576,567 7.400% | 1,576,567 (New Position) | Filing History |
| 2024-11-14 12:19 pm Unchanged | 2024-09-30 | 13G | PROTARA THERAPEUTICS INC TARA | CVI Investments, Inc. | 600,380 2.800% | 0 (Unchanged) | Filing History |
| 2024-04-25 8:43 pm Purchase | 2024-04-10 | 13G | PROTARA THERAPEUTICS INC TARA | RA CAPITAL MANAGEMENT L.P. | 2,073,075 9.990% | 393,870 (+23.46%) | Filing History |
| 2024-04-22 4:05 pm Purchase | 2024-04-10 | 13G | PROTARA THERAPEUTICS INC TARA | Citadel Advisors LLC | 1,213,132 5.700% | 1,213,132 (New Position) | Filing History |
| 2024-04-09 10:43 am Purchase | 2024-04-05 | 13G | PROTARA THERAPEUTICS INC TARA | CVI Investments, Inc. | 600,380 5.300% | 600,380 (New Position) | Filing History |
| 2024-02-14 7:11 pm Sale | 2023-12-31 | 13G | PROTARA THERAPEUTICS INC TARA | ORBIMED ADVISORS LLC | 0 0.000% | -671,741 (Position Closed) | Filing History |
| 2023-02-14 4:52 pm Unchanged | 2022-12-31 | 13G | PROTARA THERAPEUTICS INC TARA | ORBIMED ADVISORS LLC | 671,741 6.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 6:59 pm Sale | 2021-12-31 | 13G | PROTARA THERAPEUTICS INC TARA | Perceptive Advisors LLC | 421,641 3.800% | -186,903 (-30.71%) | Filing History |
| 2022-02-14 6:27 pm Sale | 2021-12-31 | 13G | PROTARA THERAPEUTICS INC TARA | Rock Springs Capital Management LP | 0 0.000% | -643,200 (Position Closed) | Filing History |
| 2022-02-14 4:39 pm Sale | 2021-12-31 | 13G | PROTARA THERAPEUTICS INC TARA | Ikarian Capital, LLC | 279,256 2.500% | -370,286 (-57.01%) | Filing History |
| 2022-02-11 4:40 pm Purchase | 2021-12-31 | 13G | PROTARA THERAPEUTICS INC TARA | ORBIMED ADVISORS LLC | 671,741 6.000% | 671,741 (New Position) | Filing History |